CDKN1A and prostate cancer: Thakur et al. demonstrated that epigallocatechin-gallate epigenetically reactivated p21/waf1, Bax and PUMA in prostate cancer cells, resulting in cell cycle arrest and apoptosis mediated by proteasomal degradation of class I HDACs [23].